...
首页> 外文期刊>The European Journal of Neuroscience >Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice.
【24h】

Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice.

机译:在阿片类鸦片受体缺陷型小鼠中缺乏deltorphin II的依赖性和奖励作用。

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously shown that the antinociceptive effects produced by the delta opioid-selective agonist deltorphin II are preserved in mu-opioid receptor (MOR)-deficient mice. We have now investigated rewarding effects and physical dependence produced by deltorphin II in these animals. Wild-type and MOR-deficient mice were implanted with a cannula into the third ventricle and deltorphin II was administered centrally. The rewarding effects induced by deltorphin II were then investigated using the place preference paradigm. Wild-type mice showed place preference for the compartment previously associated with deltorphin II and this effect was not observed in MOR-deficient mice. In a second experiment, mice received a chronic perfusion of deltorphin II over 6 days, via an Alzet minipump connected to the intraventricular cannula, and withdrawal was precipitated by naloxone administration. Wild-type animals showed a moderate but significant incidence of several somatic signs of withdrawal. This withdrawal response was suppressed in MOR-deficient mice. Analysis of the immunoreactivity levels of PKC-alpha, PKC-beta (I and II) and PKC-gamma isozymes in the cerebral cortex of mice infused chronically with deltorphin II showed a significant up-regulation of all these isozymes in the soluble fraction in wild-type but not in MOR-deficient mice. In conclusion, mu-opioid receptors, which are not involved in deltorphin II antinociception, appear to mediate the effects of chronic deltorphin II on rewarding responses, physical dependence and adaptive changes to PKC.
机译:以前我们已经表明,在阿片类阿片受体(MOR)缺陷型小鼠中保留了由δ阿片类选择性激动剂deltorphin II产生的抗伤害作用。现在,我们研究了德尔托芬II对这些动物产生的有益作用和身体依赖性。将野生型和MOR缺陷型小鼠的套管植入第三脑室,并集中给予deltorphin II。然后,使用场所偏好范式研究了德尔托芬II诱导的奖励作用。野生型小鼠表现出对先前与deltorphin II相关的区室的位置偏好,并且在MOR缺陷小鼠中未观察到这种作用。在第二个实验中,小鼠通过连接到脑室内插管的Alzet微型泵在6天之内接受了deltorphin II的慢性灌注,并且通过纳洛酮的给药使撤离沉淀。野生型动物显示出中度但显着的几种躯体退缩迹象的发生率。在MOR缺陷小鼠中,这种戒断反应受到抑制。长期注射deltorphin II的小鼠大脑皮质中PKC-α,PKC-β(I和II)和PKC-γ同工酶的免疫反应性水平分析表明,野生环境中可溶性部分中的所有这些同工酶均显着上调-型,但不能出现在MOR缺陷型小鼠中。总之,不参与deltorphin II抗伤害感受的μ阿片受体似乎介导了慢性deltorphin II对PKC的奖励反应,身体依赖性和适应性改变的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号